Cargando…
Inhibiting C5 in patients with severe COVID-19—the incorrect target?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256268/ https://www.ncbi.nlm.nih.gov/pubmed/37307842 http://dx.doi.org/10.1016/S2213-2600(23)00189-3 |
| _version_ | 1785057066044358656 |
|---|---|
| author | Lim, Endry H T Vlaar, Alexander P J Brouwer, Matthijs C van de Beek, Diederik |
| author_facet | Lim, Endry H T Vlaar, Alexander P J Brouwer, Matthijs C van de Beek, Diederik |
| author_sort | Lim, Endry H T |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10256268 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102562682023-06-12 Inhibiting C5 in patients with severe COVID-19—the incorrect target? Lim, Endry H T Vlaar, Alexander P J Brouwer, Matthijs C van de Beek, Diederik Lancet Respir Med Correspondence Elsevier Ltd. 2023-06-09 /pmc/articles/PMC10256268/ /pubmed/37307842 http://dx.doi.org/10.1016/S2213-2600(23)00189-3 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Lim, Endry H T Vlaar, Alexander P J Brouwer, Matthijs C van de Beek, Diederik Inhibiting C5 in patients with severe COVID-19—the incorrect target? |
| title | Inhibiting C5 in patients with severe COVID-19—the incorrect target? |
| title_full | Inhibiting C5 in patients with severe COVID-19—the incorrect target? |
| title_fullStr | Inhibiting C5 in patients with severe COVID-19—the incorrect target? |
| title_full_unstemmed | Inhibiting C5 in patients with severe COVID-19—the incorrect target? |
| title_short | Inhibiting C5 in patients with severe COVID-19—the incorrect target? |
| title_sort | inhibiting c5 in patients with severe covid-19—the incorrect target? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256268/ https://www.ncbi.nlm.nih.gov/pubmed/37307842 http://dx.doi.org/10.1016/S2213-2600(23)00189-3 |
| work_keys_str_mv | AT limendryht inhibitingc5inpatientswithseverecovid19theincorrecttarget AT vlaaralexanderpj inhibitingc5inpatientswithseverecovid19theincorrecttarget AT brouwermatthijsc inhibitingc5inpatientswithseverecovid19theincorrecttarget AT vandebeekdiederik inhibitingc5inpatientswithseverecovid19theincorrecttarget |